RenovoRx (RNXT) SEC Filings & 10K Form

$1.23
+0.03 (+2.50%)
(As of 04/24/2024 ET)

Recent RenovoRx SEC Filings

DateFilerForm TypeView
04/22/2024
10:26 AM
RenovoRx (Filer)
Form D
Notice of Exempt Offering of Securities 
04/18/2024
3:15 PM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
7:00 AM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
8:00 AM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
4:14 PM
RenovoRx (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/09/2024
3:15 PM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
3:53 PM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:39 PM
Kocak Ron (Reporting)
RenovoRx (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/12/2024
6:46 PM
Kocak Ron (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
3:30 PM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
6:33 PM
Agah Ramtin (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
5:57 PM
Bagai Shaun (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
6:00 PM
RenovoRx (Issuer)
Spiegel Robert J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
5:30 PM
Macfarlane K. Angela (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
5:32 PM
Marton Laurence (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
8:06 AM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
8:50 PM
Bagai Shaun (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
8:50 PM
Agah Ramtin (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
8:50 PM
Nelms Angela (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
7:30 AM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
3:15 PM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
4:30 PM
RenovoRx (Filer)
Form PRE 14A
11/13/2023
3:58 PM
RenovoRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
3:15 PM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
3:44 PM
Nelms Angela (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
3:15 PM
Macfarlane K. Angela (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
3:15 PM
Diamond David (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
3:15 PM
RenovoRx (Issuer)
RYAN UNA S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
3:15 PM
Marton Laurence (Reporting)
RenovoRx (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
3:15 PM
RenovoRx (Issuer)
Spiegel Robert J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2023
6:41 PM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2023
3:15 PM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2023
7:30 AM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
1:11 PM
RenovoRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/29/2023
8:27 AM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2023
11:15 PM
RenovoRx (Filer)
Form EFFECT
05/15/2023
7:30 AM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2023
3:18 PM
RenovoRx (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2023
8:00 AM
RenovoRx (Filer)
Form DEF 14A
04/27/2023
7:30 AM
RenovoRx (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:RNXT) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners